Bajaj Healthcare Limited Stock Price Today (NSE: BAJAJHCARE)
Fundamental Score
Bajaj Healthcare Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Bajaj Healthcare Limited share price today is ₹321.10, up +0.06% on NSE/BSE as of 16 September 2026. Bajaj Healthcare Limited (BAJAJHCARE) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹1.08K (Cr). The 52-week high for BAJAJHCARE share price is ₹515.90 and the 52-week low is ₹272.35. At a P/E ratio of 59.46x, BAJAJHCARE is currently trading above its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 3.16% and a debt-to-equity ratio of 0.44.
Bajaj Healthcare Limited Share Price Chart — NSE/BSE Historical Performance
Bajaj Healthcare Limited share price chart: 1.95% return over the past month. 52-week high ₹515.90, 52-week low ₹272.35.
Bajaj Healthcare Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹324.00 | ₹324.00 | ₹313.05 | ₹321.10 | 95.50K (Cr) | |
| ₹334.05 | ₹334.10 | ₹318.60 | ₹320.90 | 95.07K (Cr) | |
| ₹332.00 | ₹338.40 | ₹325.00 | ₹334.05 | 1.31L (Cr) | |
| ₹335.90 | ₹337.90 | ₹331.50 | ₹333.30 | 62.43K (Cr) | |
| ₹339.20 | ₹339.20 | ₹331.25 | ₹333.70 | 83.48K (Cr) | |
| ₹328.85 | ₹338.70 | ₹328.85 | ₹336.70 | 1.96L (Cr) | |
| ₹323.95 | ₹333.00 | ₹320.10 | ₹328.80 | 1.84L (Cr) | |
| ₹327.80 | ₹331.90 | ₹319.85 | ₹321.45 | 4.59L (Cr) | |
| ₹330.00 | ₹339.90 | ₹324.60 | ₹325.20 | 1.59L (Cr) | |
| ₹330.95 | ₹332.00 | ₹325.85 | ₹329.00 | 43.92K (Cr) |
Bajaj Healthcare Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹333.70 | ₹339.90 | ₹313.05 | ₹321.10 | -3.78% | |
| ₹341.00 | ₹343.60 | ₹317.00 | ₹333.70 | -2.14% | |
| ₹350.45 | ₹394.00 | ₹313.35 | ₹336.45 | -3.99% | |
| ₹306.75 | ₹364.60 | ₹281.10 | ₹351.45 | +14.57% | |
| ₹322.80 | ₹348.00 | ₹272.35 | ₹302.20 | -6.38% | |
| ₹303.20 | ₹361.90 | ₹294.15 | ₹321.75 | +6.12% | |
| ₹319.30 | ₹328.00 | ₹273.25 | ₹290.10 | -9.15% | |
| ₹341.00 | ₹386.45 | ₹328.00 | ₹329.65 | -3.33% | |
| ₹422.90 | ₹430.00 | ₹330.65 | ₹346.05 | -18.17% | |
| ₹432.50 | ₹436.50 | ₹393.45 | ₹415.10 | -4.02% | |
| ₹475.10 | ₹481.80 | ₹419.25 | ₹432.45 | -8.98% | |
| ₹489.90 | ₹506.45 | ₹445.70 | ₹475.55 | -2.93% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Bajaj Healthcare Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Bajaj Healthcare Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of BAJAJHCARE across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Strong Operating Margins (15.60%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Healthy Liquidity Position (Current Ratio: 1.89)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Balanced Promoter Holding (59.19%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
9 factors identified
Below-Average Return on Equity (3.16%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (8.79%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Premium Valuation Risk (P/E: 59.46x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Limited Growth History (-1.44% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Earnings Growth (-14.26% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (-10.79% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Weak Interest Coverage (2.30x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-107.58 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 4.89%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
Bajaj Healthcare Limited vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Bajaj Healthcare Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Bajaj Healthcare LimitedBajaj Healthcar...Selected✓ BAJAJHCARE • 539872 | 30.3/100 | ₹321.10₹321 | ₹1080.91₹1080.91 | 59.46Average 59.5 Average | 3.16%Poor 3.16% Poor | 8.79%Poor 8.79% Poor | 0.44Excellent 0.4 Excellent | -10.79%Poor -10.79% Poor | -1.44%Poor -1.44% Poor | 0.28% |
Sun Pharmaceutical Industries LimitedSun Pharmaceuti... SUNPHARMA • 524715 | 66.4/100 | ₹1869.10₹1869 | ₹448453.16₹448453.16 | 37.09Average 37.1 Average | 14.74%Average 14.74% Average | 19.31%Good 19.31% Good | 0.05Excellent 0.0 Excellent | 31.64%Excellent 31.64% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divi's Laboratories LimitedDivi's Laborato... DIVISLAB • 532488 | 56.3/100 | ₹9460.50₹9461 | ₹250703.25₹250703.25 | 85.84Average 85.8 Average | 16.19%Good 16.19% Good | 20.38%Excellent 20.38% Excellent | 0.00Excellent 0.0 Excellent | 5.29%Good 5.29% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LimitedTorrent Pharmac... TORNTPHARM • 500420 | 51.4/100 | ₹4942.00₹4942 | ₹167266.93₹167266.93 | 78.95Average 78.9 Average | 27.07%Excellent 27.07% Excellent | 14.09%Average 14.09% Average | 1.76Average 1.8 Average | 11.56%Good 11.56% Good | 11.80%Good 11.80% Good | 0.76% |
Zydus Lifesciences LimitedZydus Lifescien... ZYDUSLIFE • 532321 | 74.1/100 | ₹1130.60₹1131 | ₹112833.88₹112833.88 | 25.20Average 25.2 Average | 19.74%Good 19.74% Good | 21.77%Excellent 21.77% Excellent | 0.43Excellent 0.4 Excellent | 18.76%Excellent 18.76% Excellent | 12.45%Good 12.45% Good | 0.09% |
Cipla LimitedCipla Limited... CIPLA • 500087 | 40.2/100 | ₹1370.70₹1371 | ₹110732.00₹110732.00 | 32.84Average 32.8 Average | 11.82%Average 11.82% Average | 15.67%Good 15.67% Good | 0.01Excellent 0.0 Excellent | 10.03%Good 10.03% Good | 8.01%Good 8.01% Good | 0.90% |
Laurus Labs LimitedLaurus Labs Lim... LAURUSLABS • 540222 | 34.1/100 | ₹1934.30₹1934 | ₹104500.56₹104500.56 | 95.47Average 95.5 Average | 18.19%Good 18.19% Good | 21.35%Excellent 21.35% Excellent | 0.45Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Aurobindo Pharma LimitedAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1675.90₹1676 | ₹96431.29₹96431.29 | 26.19Average 26.2 Average | 9.94%Poor 9.94% Poor | 14.54%Average 14.54% Average | 0.20Excellent 0.2 Excellent | -8.07%Poor -8.07% Poor | 6.32%Good 6.32% Good | 0.26% |
Lupin LimitedLupin Limited... LUPIN • 500257 | 83.4/100 | ₹2098.30₹2098 | ₹95944.77₹95944.77 | 17.34Average 17.3 Average | 26.90%Excellent 26.90% Excellent | 31.80%Excellent 31.80% Excellent | 0.26Excellent 0.3 Excellent | 34.39%Excellent 34.39% Excellent | 13.02%Good 13.02% Good | 0.72% |
Dr. Reddy's Laboratories LimitedDr. Reddy's Lab... DRREDDY • 500124 | 41/100 | ₹1145.40₹1145 | ₹95640.90₹95640.90 | 29.60Average 29.6 Average | 11.75%Average 11.75% Average | 14.80%Average 14.80% Average | 0.17Excellent 0.2 Excellent | 16.54%Excellent 16.54% Excellent | 12.09%Good 12.09% Good | 0.65% |
Mankind Pharma LimitedMankind Pharma ... MANKIND • 543904 | 61.5/100 | ₹2269.50₹2270 | ₹93730.35₹93730.35 | 45.86Average 45.9 Average | 12.49%Average 12.49% Average | 13.56%Average 13.56% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Limited share price448453.16 Cr
- Divi's Laboratories Limited share price250703.25 Cr
- Torrent Pharmaceuticals Limited share price167266.93 Cr
- Zydus Lifesciences Limited share price112833.88 Cr
- Cipla Limited share price110732.00 Cr
Bajaj Healthcare Limited PE Ratio History
Historical price-to-earnings ratio for BAJAJHCARE — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹13.12 | ₹415.10 | 31.6x |
| FY 2023 | ₹15.59 | ₹376.00 | 24.1x |
| FY 2022 | ₹25.87 | ₹444.60 | 17.2x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Bajaj Healthcare Limited Dividend History
Annual cash dividends paid by BAJAJHCARE — dividend yield 0.28%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹2.76 Cr |
| FY 2024 | ₹2.76 Cr |
| FY 2023 | ₹4.14 Cr |
| FY 2022 | ₹1.38 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Bajaj Healthcare Limited Quarterly Performance
Latest quarterly metrics for BAJAJHCARE — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
11.28%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
15.75%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
-1.44%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
-10.79%
Compounded annual net profit growth over 5 years
Bajaj Healthcare Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for BAJAJHCARE — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Bajaj Healthcare Limited Financial Statements
Annual income statement, balance sheet and cash flow for Bajaj Healthcare Limited (BAJAJHCARE) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Bajaj Healthcare Limited
About BAJAJHCARE (Bajaj Healthcare Limited)
Bajaj Healthcare Limited (BAJAJHCARE) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Pharmaceuticals sector wi...th a current market capitalisation of ₹1.08K (Cr). Bajaj Healthcare Limited has delivered a Return on Equity (ROE) of 3.16% and a ROCE of 8.79%. The debt-to-equity ratio stands at 0.44, reflecting the company's capital structure. Investors tracking BAJAJHCARE share price can monitor key metrics including P/E ratio, promoter holding of 59.19%, and quarterly earnings growth.
Company Details
Key Leadership
BAJAJHCARE Share Price: Frequently Asked Questions
What is the current share price of Bajaj Healthcare Limited?
Bajaj Healthcare Limited (BAJAJHCARE) trades at ₹321.10 on NSE and BSE. Market cap ₹1.08K (Cr). Educational data only.
What is the P/E ratio of Bajaj Healthcare Limited?
Bajaj Healthcare Limited has a P/E of 59.46x vs industry average 34.89x.
What is the Bull Run score for Bajaj Healthcare Limited?
Bajaj Healthcare Limited has a Bull Run score of 30.3/100 based on 25+ financial parameters.
Does Bajaj Healthcare Limited pay dividends?
Bajaj Healthcare Limited has a dividend yield of 0.28%. Past dividends don't guarantee future payments.
What is the ROE of Bajaj Healthcare Limited?
Bajaj Healthcare Limited has ROE of 3.16%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Bajaj Healthcare Limited?
Bajaj Healthcare Limited has debt-to-equity of 0.44.
Is Bajaj Healthcare Limited a good investment?
Bull Run gives Bajaj Healthcare Limited a score of 30.3/100. This is not investment advice — consult a SEBI-registered advisor.